Actinium Pharmaceuticals
ATNM
#9985
Rank
A$46.59 M
Marketcap
A$1.49
Share price
-4.60%
Change (1 day)
-19.04%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -A$58.74 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.09 Million. In 2024 the company made an earning of -A$59.42 Million, an increase over its 2023 earnings that were of -A$73.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.74 Million-1.14%
2024 -A$59.42 Million-18.87%
2023 -A$73.24 Million52.24%
2022 -A$48.11 Million36.61%
2021 -A$35.22 Million11.48%
2020 -A$31.59 Million1.46%
2019 -A$31.14 Million-7.37%
2018 -A$33.62 Million-11.46%
2017 -A$37.97 Million10.67%
2016 -A$34.31 Million15.7%
2015 -A$29.65 Million-14.86%
2014 -A$34.83 Million129.19%
2013 -A$15.2 Million-8.55%
2012 -A$16.62 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.04 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-A$52.47 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$7.02 M-113.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.95 B-1,919.25%๐Ÿ‡บ๐Ÿ‡ธ USA